Petros Pharmaceuticals, Inc. reports developments in over-the-counter drug development programs and technology designed to support prescription-to-OTC switches. The company is developing a proprietary SaaS platform and Software as a Medical Device web application intended to assist pharmaceutical sponsors with FDA standards under the Additional Conditions for Nonprescription Use framework.
Recurring company updates include AI, big data, electronic health record, identity verification, cybersecurity and patient self-selection components of the platform; collaborations with software and data providers; application comprehension study results; and corporate actions affecting its balance sheet, subsidiary structure and trading status on OTC markets.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.